Phosphoinositide 3-kinase delta selective inhibitors for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/52 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2566436

The invention relates generally to methods for inhibiting angiogenesis. More particularly, methods for inhibiting angiogenesis comprise selectively inhibiting phosphoinositide 3-kinase delta (P13K.delta.) activity in endothelial cells. The methods may comprise administration of one or more cytotoxic therapies including but not limited to radiation, chemotherapeutic agents, photodynamic therapies, radiofrequency ablation, anti-angiogenic agents, and combinations thereof.

L'invention concerne généralement des procédés pour inhiber l'angiogenèse. Plus particulièrement, des procédés pour inhiber l'angiogenèse comprennent sélectivement l'inhibition de l'activité de la phosphoinositide-3-kinase delta (P13K.delta.) dans les cellules endothéliales. Les procédés peuvent comprendre l'administration d'une ou plusieurs thérapies cytotoxiques, y compris entre autres l~irradiation, les agents chimiothérapiques, les thérapies photodynamiques, l~ablation par radiofréquence, les agents anti-angiogéniques, et les combinaisons de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Phosphoinositide 3-kinase delta selective inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phosphoinositide 3-kinase delta selective inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphoinositide 3-kinase delta selective inhibitors for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1982485

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.